Related Articles
Alternative splicing of ERCC1 and cisplatin-DNA adduct repair in human tumor cell lines.
β-Elemene enhances susceptibility to cisplatin in resistant ovarian carcinoma cells via downregulation of ERCC-1 and XIAP and inactivation of JNK
Combinatorial treatment of ovarian cancer cells with harringtonine and cisplatin results in increased cisplatin-DNA adducts
Effects of gemcitabine on cis-platinum-DNA adduct formation and repair in a panel of gemcitabine and cisplatin-sensitive or -resistant human ovarian cancer cell lines
PRELIMINARY-STUDY OF THE EFFECT OF SELECTED CHINESE NATURAL DRUGS ON HUMAN OVARIAN-CANCER CELLS